Medical Research

Metformin use is associated with reduced cancer risk

April 25, 2024 - Two recent studies published in the Journal of the National Cancer Institute have correlated metformin use with lower cancer risks, implying that the drug may offer some protection against the illness. The first of these studies was a systematic review and meta-analysis published earlier this year. Researchers used databases such as PubMed,...

Read More


More Articles

Strategies for engaging, managing KOLs in the pharma industry

by Veronica Salib

Key opinion leaders (KOLs) are healthcare providers (HCPs) and industry leaders who play a critical role in the healthcare industry, acting as vital stakeholders for the sector, including life sciences and pharmaceutical companies....

Addressing muscle loss associated with GLP-1 medication use

by Veronica Salib

Glucagon-like peptide-1 (GLP-1) receptor agonists — also known as GLP-1 drugs — have gained a significant amount of attention in recent years because of their utility in managing type 2 diabetes (T2D) and, even more so, in...

Age-adjusted drug overdose deaths stabilized from 2021 to 2022

by Veronica Salib

A CDC analysis noted that between 2021 and 2022, the age-adjusted rate of drug overdose deaths did not change significantly, a variation from previous years where the rates climbed overall. However,...

Acne treatments contain harmful levels of benzoyl peroxide

by Veronica Salib

On March 6, 2024, Valisure, an independent quality assurance lab, issued a press release identifying harmfully high levels of benzoyl peroxide in multiple skincare products, specifically products...

Semaglutide Minimizes MASLD Severity in Patients with HIV

by Veronica Salib

On Tuesday, March 5, 2024, the NIH issued a release linking semaglutide use with a decreased severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in HIV-positive patients,...

NIH Launches Cancer Screening Research Network for Early Detection

by Veronica Salib

On Wednesday, February 21, 2024, the NIH launched a clinical trial network for evaluating new cancer detection technologies or methods called the Cancer Screening Research Network (CSRN), which will...

Injectable HIV ART Is an Effective Alternative to Oral Medications

by Veronica Salib

On February 21, 2024, the NIH issued a press announcement revealing that long-acting injectable antiretroviral therapy (ART) using cabotegravir and rilpivirine was more effective than oral ART at...

FDA Approves New First-Line Treatment for Pancreatic Adenocarcinoma

by Veronica Salib

Adding to existing pancreatic cancer treatment options, the United States FDA granted Ipsen Biopharmaceuticals approval for Onivyde — generically known as irinotecan liposome — for treating...

What Is the Role of the Accelerating Medicines Partnership?

by Veronica Salib

Last week, the Foundation for the National Institutes of Health (FNIH) held its inaugural Accelerating Medicines Partnership (AMP) Program Symposium, discussing the progress of multiple AMP projects. Julie Gerberding, MD, MPH, President...

10% of Premature Births Linked to Phthalate Exposure In Utero

by Veronica Salib

Earlier this week, researchers revealed that approximately 10% of premature births in the United States are linked to prenatal phthalate exposure in a study published in the Lancet Planetary...

GLP-1 Receptor Agonists Reduce 24-Hour Ambulatory Blood Pressure

by Veronica Salib

On Monday, February 5, 2024, a research letter published in Hypertension highlighted the benefit of tirzepatide in managing high blood pressure using data from the SURMOUNT study. The letter notes a...

Vertex Non-Opioid Drug Is an Effective Pain Management Medication

by Veronica Salib

On Tuesday, January 30, 2024, Vertex Pharmaceuticals issued a press release announcing that VX-548, its non-opioid pain management drug, effectively reduced pain compared to the placebo across multiple...

Patients Maintain Weight Loss One Year After Discontinuing GLP-1 Drugs

by Veronica Salib

Earlier this week, Epic Research published a dual-team Cosmos study assessing how stopping glucagon-like peptide-1 (GLP-1) receptor agonists, sometimes called GLP-1 drugs, can impact long-term weight...

Ethical Guidelines, Emerging Regulations in Octopus Research

by Alivia Kaylor

With their unique biological features, octopuses have become valuable subjects in medical research. Their extraordinary abilities, such as camouflage, regenerative capabilities, and highly developed nervous systems, make them captivating...

Researcher Study Non-Opioid Pain Medication for Diabetic Neuropathy

by Veronica Salib

On the tail of their win as the first FDA-approved CRISPR-based gene editing therapy, Vertex Pharmaceuticals announced the results of a phase 2 clinical trial for VX-548, a non-opioid pain management...

NIH Alters Grant Review Process, Focusing on Scientific Merit

by Veronica Salib

On October 19, 2023, the National Institutes of Health (NIH) announced plans to alter and simplify its grant review process, attempting to eliminate reputational bias in grant allocation. The updated...

Nektar Sues Eli Lilly for Incorrect Clinical Trial Results

by Hayden Schmidt

On Monday, Nektar Therapeutics released a scathing public statement that accused its former partner, Eli Lilly, of miscalculating and sharing clinical trial results that underrepresented the...

New Reagent Delivers Biomolecules to Lung Tissue to Treat Lung Disease

by Veronica Salib

On August 2, 2023, Altogen Biosystems announced and launched a new targeted reagent that can deliver biomolecules to the lungs, treating pulmonary diseases. According to the announcement, the drug has...

How Do Nonprofit Pharmaceutical Companies Get Funding?

by Veronica Salib

On July 28, 2023, the United States Food and Drug Administration (FDA) approved ReVive, an opioid reversal medication manufactured by Harm Reduction Therapeutics, a nonprofit pharmaceutical company. The concept of a nonprofit...

Recent Articles